Vimarsana
Biggest News Aggregation in the World

Comprehensive Score News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Comprehensive Score. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Comprehensive Score Today - Breaking & Trending Today

Financial Toxicity High With Myeloma, Navigation May Help Find Aid, Solutions - Vimarsana News

Financial Toxicity High With Myeloma, Navigation May Help Find Aid, Solutions

A pilot project at a Philadelphia cancer center sought to improve awareness of financial assistance resources for patients with multiple myeloma.

Financial Navigation Program May Alleviate Cost Burden Associated With Multiple Myeloma - Vimarsana News

Financial Navigation Program May Alleviate Cost Burden Associated With Multiple Myeloma

Utilization of a financial navigation program is feasible for reducing cost burden and improving quality of life in patients with multiple myeloma who are more likely to experience financial toxicity and have difficulty accessing appropriate resources and support services.

Financial Navigation Programs Are 'Efficient' for Some With Multiple Myeloma - Vimarsana News

Financial Navigation Programs Are 'Efficient' for Some With Multiple Myeloma

Study findings support the use of a financial navigation program, in hopes of aiding patients with multiple myeloma affected by financial toxicity.

Some Patient Characteristics Lower Financial Toxicity in Metastatic Prostate Cancer - Vimarsana News

Some Patient Characteristics Lower Financial Toxicity in Metastatic Prostate Cancer

Financial hardship related to treatment costs is a common reality for many men with metastatic prostate cancer.

Financial Toxicity Seen in 3 of 4 HSCT-Eligible Patients With Leukemia - Vimarsana News

Financial Toxicity Seen in 3 of 4 HSCT-Eligible Patients With Leukemia

The researchers of a new study highlighted the unique financial burden facing these patients, eligible for hematopoietic stem cell transplantation (HSCT), who often require lengthy hospitalizations and have associated risks of acute and chronic morbidity.

Source: ajmc.com